Top Pharmaceuticals Stocks by Volume Traded
Last Updated on: Apr 28, 2025
List of Top Pharmaceuticals Stocks By Net Profit
| Company Name | Volume |
|---|
| Morepen Laboratories Ltd | 26325755 |
| Ranbaxy Laboratories Ltd (Merged) | 5415702 |
| Piramal Pharma Ltd | 4065651 |
| Sigachi Industries Ltd | 4013435 |
| Sun Pharmaceutical Industries Ltd | 3216482 |
| Biocon Ltd | 2427466 |
| Laurus Labs Ltd | 2030722 |
| Syncom Formulations (India) Ltd | 1844736 |
| Dishman Pharmaceuticals and Chemicals Ltd(Merged) | 1615604 |
| Zydus Lifesciences Ltd | 1527151 |
| Company Name |  Volume |
|---|---|
| Morepen Laboratories Ltd | 26325755 |
| Ranbaxy Laboratories Ltd (Merged) | 5415702 |
| Piramal Pharma Ltd | 4065651 |
| Sigachi Industries Ltd | 4013435 |
| Sun Pharmaceutical Industries Ltd | 3216482 |
| Biocon Ltd | 2427466 |
| Laurus Labs Ltd | 2030722 |
| Syncom Formulations (India) Ltd | 1844736 |
| Dishman Pharmaceuticals and Chemicals Ltd(Merged) | 1615604 |
| Zydus Lifesciences Ltd | 1527151 |
FAQ's For Top Pharmaceuticals Stocks By Volume Traded
What is the EPS of Axles India Ltd stock?
The Earnings Per Share (EPS) of Axles India Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.
How is Axles India Ltd EPS calculated?
The EPS of Axles India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.
How often does Axles India Ltd report its EPS?
Axles India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.
What factors can influence Axles India Ltd EPS?
Factors that influence the EPS of Axles India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.
Can Axles India Ltd EPS growth indicate future performance?
Yes, consistent growth in Axles India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Unlimited trading starting at just Rs. 249*
